Medicare Enrolled

Dr. Ravinder Singh, MD

Neurology · Beverly Hills, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
8920 WILSHIRE BLVD, Beverly Hills, CA 90211
3104322880
In practice since 2006 (19 years)
NPI: 1184648990 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Singh

Dr. Ravinder Singh is a neurology specialist in Beverly Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 7,873 Medicare services across 3,376 unique beneficiaries.

Between the years covered by Open Payments, Dr. Singh received a total of $50,038 from 37 pharmaceutical and/or device companies across 299 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 12% volume in CA $50,038 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,873
Medicare services
Top 12% in CA for neurology
3,376
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~414 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
4,847 $66 $240
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
1,282 $144 $300
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
1,158 $100 $325
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
207 $75 $150
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
154 $95 $250
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
104 $47 $800
New patient office visit, complex (60-74 min) 42 $168 $595
Home visit, established patient, low complexity
A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes.
21 $64 $200
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
17 $177 $300
Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes 17 $68 $500
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
12 $154 $395
Home visit, new patient, moderate complexity
A home visit for a new patient involving moderate medical decision making, lasting at least 60 minutes.
12 $121 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$50,038
Total received (2018-2024)
Avg $7,148/year across 7 years
Top 9% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
299
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$44,486 (88.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,552 (11.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$9,999
2023
$1,417
2022
$790
2021
$6,496
2020
$10,318
2019
$20,195
2018
$823

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$9,637
ABBVIE INC.
$192
Neurelis, Inc.
$61
Lundbeck LLC
$29
PFIZER INC.
$29
ACADIA Pharmaceuticals Inc
$28
Otsuka America Pharmaceutical, Inc.
$24
Top 3 companies account for 98.9% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$35,030
Teva Pharmaceuticals USA, Inc.
$10,424
AbbVie Inc.
$657
UCB, Inc.
$616
ABBVIE INC.
$501
Allergan Inc.
$277
Allergan, Inc.
$238
Amgen Inc.
$231
Novartis Pharmaceuticals Corporation
$215
Neurelis, Inc.
$209
Lundbeck LLC
$170
US WorldMeds, LLC
$139
SK Life Science, Inc.
$133
PFIZER INC.
$126
Upsher-Smith Laboratories LLC
$110
IMPEL PHARMACEUTICALS INC.
$104
Impax Laboratories, Inc.
$73
ACADIA Pharmaceuticals Inc
$72
Zyla Life Sciences, Inc.
$67
UPSHER-SMITH LABORATORIES LLC
$67
Shire North American Group Inc
$65
Amneal Pharmaceuticals LLC
$65
Eisai Inc.
$44
Biogen, Inc.
$43
CSL Behring
$42
Bayer HealthCare Pharmaceuticals Inc.
$41
GENZYME CORPORATION
$37
Neurocrine Biosciences, Inc.
$34
Mallinckrodt Hospital Products Inc.
$33
Assertio Therapeutics, Inc.
$32
Otsuka America Pharmaceutical, Inc.
$24
Arbor Pharmaceuticals, Inc.
$23
MITSUBISHI TANABE PHARMA AMERICA, INC.
$23
Biohaven Pharmaceuticals, Inc.
$20
Sunovion Pharmaceuticals Inc.
$19
Zyla Life Sciences
$18
Strongbridge US INC.
$14
Top 3 companies account for 92.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APTIOM · AUSTEDO · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BYSTOLIC · Betaseron · Briviact · CAMBIA · COMIRNATY · Dayvigo · EMGALITY · Eprontia · Fycompa · GAMMAGARD · Hizentra · INGREZZA · KEVEYIS · MYOBLOC · NUPLAZID · NURTEC ODT · OCTAGAM IMMUNE GLOBULIN (HUMAN) · PANZYGA · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RYTARY · SPRIX · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · Trudhesa · UBRELVY · VALTOCO · VRAYLAR · VYEPTI · Vimpat · XCOPRI · Xadago · ZOMIG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for neurology in CA.

Looking for a neurology specialist in Beverly Hills?
Compare neurologists in the Beverly Hills area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
548
Per 100K population
5.6
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Singh is a mixed practice specialist, with above-average Medicare volume (top 12% in CA), with speaking/promotional industry engagement in the top 9% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Singh experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Singh performed 4,847 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $50,038 from 37 companies across 299 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other neurologists in Beverly Hills?
Dr. Singh's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →